<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03237910</url>
  </required_header>
  <id_info>
    <org_study_id>IRFMN-7167-7429</org_study_id>
    <nct_id>NCT03237910</nct_id>
  </id_info>
  <brief_title>Real Time Amplitude Spectrum Area to Guide Defibrillation</brief_title>
  <acronym>AMSA</acronym>
  <official_title>AMplitude Spectrum Area to Guide Defibrillation During Cardiopulmonary Resuscitation in Out-of-hospital Cardiac Arrest Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mario Negri Institute for Pharmacological Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Commission</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zoll Medical Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Mario Negri Institute for Pharmacological Research</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      AMSA trial is a multicenter, randomized, controlled study in out-of-hospital cardiac arrest&#xD;
      patients.&#xD;
&#xD;
      The purpose of the study is to test the hypothesis that a real time AMSA analysis during CPR&#xD;
      may predict the success of defibrillation and optimize the timing of defibrillation delivery.&#xD;
&#xD;
      The primary end-point is the efficacy of the AMSA-CPR: termination of VF/VT with achievement&#xD;
      of ROSC for an AMSA ≥ 15.5 mV-Hz&#xD;
&#xD;
      All patients meeting inclusion/exclusion criteria and receiving cardiopulmonary resuscitation&#xD;
      are randomized into two groups: AMSA-guided CPR or standard CPR.&#xD;
&#xD;
      In the AMSA-CPR group, AMSA value suggests when the rescuer should deliver the defibrillation&#xD;
      attempt; In the Standard-CPR group, the defibrillation is delivered based on the 2015&#xD;
      European Resuscitation Council (ERC) CPR guidelines.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the AMSA-CPR intervention, upon arrival of the advanced life support (ALS) rescue team at&#xD;
      the cardiac arrest scene and application of the defibrillatory pads to the patient's chest&#xD;
      and power on of the defibrillator with the real time AMSA analysis:&#xD;
&#xD;
        -  If AMSA is ≥ 15.5 mV-Hz, an immediate defibrillation is attempted, followed by CPR&#xD;
&#xD;
        -  If AMSA is &lt; 15.5 mV-Hz, defibrillation is not attempted and CPR is delivered&#xD;
&#xD;
        -  During the 2-min cycle of CPR, AMSA is measured during pauses for ventilations (every 30&#xD;
           CC, approximately every 20/25 sec). If an AMSA value ≥ 15.5 mV-Hz is achieved prior to&#xD;
           cycle completion, an immediate defibrillation is delivered (thus the defibrillation&#xD;
           attempt is anticipated)&#xD;
&#xD;
      After completion of the first 2-min CPR cycle:&#xD;
&#xD;
        -  If AMSA is ≤ 6.5 mV-Hz, the defibrillation is not attempted but CPR is continued&#xD;
&#xD;
        -  If AMSA is &gt; 6.5 mV-Hz, an immediate defibrillation attempt is delivered, followed by&#xD;
           CPR&#xD;
&#xD;
        -  During the 2-min cycle of CPR, AMSA is measured during pauses for ventilations (every 30&#xD;
           CC, approximately every 20/25 sec). If an AMSA value ≥ 15.5 mV-Hz is achieved prior to&#xD;
           cycle completion, an immediate defibrillation is delivered&#xD;
&#xD;
      After completion of the second 2-min CPR cycle and till the end of the resuscitative&#xD;
      intervention:&#xD;
&#xD;
      • CPR is continued based on standard 2015 ERC guidelines (a defibrillation attempt every&#xD;
      2-min CPR cycles), except for the possibility to anticipate the defibrillation attempt if&#xD;
      AMSA becomes ≥ 15.5 mV-Hz during the CPR cycle.&#xD;
&#xD;
      In the standard CPR intervention, upon arrival of the ALS team at the cardiac arrest scene,&#xD;
      and application of the defibrillatory pads to the patient's chest and power on of the&#xD;
      defibrillator:&#xD;
&#xD;
      • a defibrillation is immediately attempted and CPR is then started and continued for 2- min.&#xD;
      Analysis of rhythm and subsequent defibrillation attempts are performed every 2-min CPR&#xD;
      cycles.&#xD;
&#xD;
      In both study groups, the quality of CC and ventilation is monitored in real time thought the&#xD;
      feedback integrated into the defibrillator.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    low rate recruitment&#xD;
  </why_stopped>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Actual">July 26, 2021</completion_date>
  <primary_completion_date type="Actual">July 26, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Return of spontaneous circulation (ROSC)</measure>
    <time_frame>At day 0: from date of initiation of the cardiopulmonary resuscitation (CPR) maneuvres up to ROSC or up to 1 hour of CPR (which comes first)</time_frame>
    <description>Termination of ventricular fibrillation with achievement of ROSC for an AMSA value ≥ 15.5 mV-Hz</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Defibrillation attempts</measure>
    <time_frame>At day 0: from date of initiation of the cardiopulmonary resuscitation (CPR) maneuvres up to ROSC or up to 1 hour of CPR (which comes first)</time_frame>
    <description>Number of defibrillations to achieve ROSC</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CPR duration</measure>
    <time_frame>At day 0: from date of initiation of the cardiopulmonary resuscitation (CPR) maneuvres up to ROSC or up to 1 hour of CPR (which comes first)</time_frame>
    <description>duration of CPR in minutes prior to achieve ROSC</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac troponins</measure>
    <time_frame>at 6 and 24 hours after ICU admission</time_frame>
    <description>assessment of circulating levels of high sensitive cardiac troponin T in plasma as marker of cardiac injury</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short term survival</measure>
    <time_frame>at hospital admission and 24 hours after ROSC</time_frame>
    <description>number of patients alive after initial resuscitation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long term survival</measure>
    <time_frame>at 1 and 6 months after ROSC</time_frame>
    <description>number of patients alive after initial resuscitation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Out-Of-Hospital Cardiac Arrest</condition>
  <condition>Ventricular Fibrillation</condition>
  <arm_group>
    <arm_group_label>AMSA-CPR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The professional rescuer decides to deliver the defibrillation attempt based on the AMSA value displayed in the defibrillator</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard-CPR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The defibrillation is delivered based on the 2015 European Resuscitation Council CPR guidelines</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>AMSA</intervention_name>
    <description>A non-invasive and real time VF (Amplitude Spectrum Area) AMSA analysis is performed during chest compression pauses for delivery of 2 ventilations, from the ECG acquired from the conventional defibrillatory pads</description>
    <arm_group_label>AMSA-CPR</arm_group_label>
    <other_name>VF waveform analysis</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Defibrillation</intervention_name>
    <description>delivery of the defibrillation is attempted to terminate VF either based on AMSA value (in the AMSA-CPR arm) or every 2-min CPR cycle as recommended by current guidelines (in the Standard-CPR arm)</description>
    <arm_group_label>AMSA-CPR</arm_group_label>
    <arm_group_label>Standard-CPR</arm_group_label>
    <other_name>electric countershock</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CPR</intervention_name>
    <description>chest compressions and ventilations at a rate of 30:2</description>
    <arm_group_label>AMSA-CPR</arm_group_label>
    <arm_group_label>Standard-CPR</arm_group_label>
    <other_name>resuscitation maneuvres</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        All adult patients (age ≥ 18) suffering of out-of-hospital non traumatic cardiac arrest of&#xD;
        presumably cardiac etiology with a presenting shockable rhythm requiring electrical&#xD;
        defibrillation: Ventricular Fibrillation and pulseless Ventricular Tachycardia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age &lt; 18 years old&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  cardiac arrest with a non-shockable rhythm (pulseless electrical activity and&#xD;
             asystole)&#xD;
&#xD;
          -  a defibrillation delivered by an AED prior to ALS arrival&#xD;
&#xD;
          -  cardiac arrest of traumatic origin&#xD;
&#xD;
          -  non-cardiac cause of cardiac arrest&#xD;
&#xD;
          -  presumable irreversible death or known terminal illness at the beginning of ALS&#xD;
&#xD;
          -  clinical death&#xD;
&#xD;
          -  participation in another clinical or device trial within the previous 30 days&#xD;
&#xD;
          -  refused informed consent to the use of data.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giuseppe Ristagno, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Istituto Di Ricerche Farmacologiche Mario Negri</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roberto Latini, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Istituto Di Ricerche Farmacologiche Mario Negri</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UOC Rianimazione-Emergenza Territoriale 118, Dipartimento di Emergenza, Ospedale Maggiore - AUSL di Bologna</name>
      <address>
        <city>Bologna</city>
        <zip>40124</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SOREU Metropolitana - AREU ASST, Grande Ospedale Metropolitano Niguarda</name>
      <address>
        <city>Milano</city>
        <zip>20162</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <link>
    <url>http://cordis.europa.eu/project/rcn/207233_en.html</url>
    <description>EU Framework Horizon 2020 Programme under grant agreement no. 733381: European Sudden Cardiac Arrest network: towards Prevention, Education and New Treatment (ESCAPE-NET)</description>
  </link>
  <link>
    <url>https://www.erc.edu/projects/escape-net</url>
    <description>ESCAPE NET in ERC website</description>
  </link>
  <link>
    <url>https://www.escardio.org/Sub-specialty-communities/European-Heart-Rhythm-Association-(EHRA)/Research/escape-net</url>
    <description>ESCAPE NET in EHRA website</description>
  </link>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 21, 2017</study_first_submitted>
  <study_first_submitted_qc>July 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 3, 2017</study_first_posted>
  <last_update_submitted>September 6, 2021</last_update_submitted>
  <last_update_submitted_qc>September 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>amplitude spectrum area</keyword>
  <keyword>defibrillation</keyword>
  <keyword>waveform analysis</keyword>
  <keyword>cardiopulmonary resuscitation</keyword>
  <keyword>cardiac arrest</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Out-of-Hospital Cardiac Arrest</mesh_term>
    <mesh_term>Ventricular Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

